cd106 (R&D Systems)
94
Structured Review
R&D Systems
cd106
Cd106, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 16 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vcam+1/Human+VCAM-1%2FCD106+Antibody/pmc12993400-7-0-2
Average 94 stars, based on 16 article reviews
Cd106, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 16 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vcam+1/Human+VCAM-1%2FCD106+Antibody/pmc12993400-7-0-2
Average 94 stars, based on 16 article reviews
cd106 - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
other:Article Title: The activation of INF2 by Piezo1/Ca 2+ is required for mesenchymal-to-amoeboid transition in confined environments. Article Snippet: Article Article Title: Neural and vascular cellular adhesion molecules are associated with cognitive function in patients with schizophrenia-spectrum disorders: A longitudinal study. Article Snippet: Levels of ICAM-1 (Cat# DY720, sensitivity 7 pg/mL, dilution 500×), VCAM-1 (Cat# DY809, sensitivity 19 pg/mL, dilution 500×), MADCAM (Cat# DY6056–05, sensitivity 20 pg/mL, dilution 15×), P-selectin (Cat# DY137, sensitivity 7 pg/mL, dilution 15×), and N-CAD (DY1388–05, sensitivity 12 pg/mL, dilution 3×) were measured in duplicate using enzyme-linked immunoassays (ELISAs) with commercially available Clinical Proteomics:Article Title: Acute blood loss anemia aggravates endothelial dysfunction after acute myocardial infarction Article Snippet: .. Plasma samples were used to assess inflammatory parameters in the different mice groups by using ELISA kits for Enzyme-linked Immunosorbent Assay:Article Title: Acute blood loss anemia aggravates endothelial dysfunction after acute myocardial infarction Article Snippet: .. Plasma samples were used to assess inflammatory parameters in the different mice groups by using ELISA kits for Article Title: Association between extracellular DNA levels, markers of inflammation and left ventricular mass index in children with chronic kidney disease. Article Snippet: Plasma cathelicidin LL-37 was measured by ELISA kit from Hycult Biotech, Uden, the Netherlands. .. Pentraxin-3, IL-6, Membrane:Article Title: Decursin‐Loaded Nanovesicles Target Macrophages Driven by the Pathological Process of Atherosclerosis Article Snippet: Consequently, ALD@EM represents a promising nanocarrier system for increasing the therapeutic efficacy of antiatherosclerotic agents such as decursin, offering potential advancements in the management and treatment of atherosclerosis. .. The following materials were used in this study: decursin (SML0786, Sigma‒Aldrich); Mem‐PERTM Plus Membrane Protein Extraction Kit (89 842, Thermo Fisher); Oil Red O Staining Kit (C0157S, Beyotime), Nile Red (72 485, Sigma‒Aldrich), Coomassie Brilliant Blue Staining (P0017, Beyotime); dimethyl sulfoxide (276 855, Sigma‒Aldrich), DSPE‐PEG‐NHS (HY‐W441014, MedChemExpress), low density lipoprotein (L3486, Thermo Fisher); Enhanced Cell Counting Kit‐8 (C0041, Beyotime); DiD (C1039, Beyotime); Calcein/PI Live/Dead Cell Viability/Cytotoxicity Assay Kit (C2015 M, Beyotime); and antibodies against ICAM‐1 (ab171123, Abcam), Protein Extraction:Article Title: Decursin‐Loaded Nanovesicles Target Macrophages Driven by the Pathological Process of Atherosclerosis Article Snippet: Consequently, ALD@EM represents a promising nanocarrier system for increasing the therapeutic efficacy of antiatherosclerotic agents such as decursin, offering potential advancements in the management and treatment of atherosclerosis. .. The following materials were used in this study: decursin (SML0786, Sigma‒Aldrich); Mem‐PERTM Plus Membrane Protein Extraction Kit (89 842, Thermo Fisher); Oil Red O Staining Kit (C0157S, Beyotime), Nile Red (72 485, Sigma‒Aldrich), Coomassie Brilliant Blue Staining (P0017, Beyotime); dimethyl sulfoxide (276 855, Sigma‒Aldrich), DSPE‐PEG‐NHS (HY‐W441014, MedChemExpress), low density lipoprotein (L3486, Thermo Fisher); Enhanced Cell Counting Kit‐8 (C0041, Beyotime); DiD (C1039, Beyotime); Calcein/PI Live/Dead Cell Viability/Cytotoxicity Assay Kit (C2015 M, Beyotime); and antibodies against ICAM‐1 (ab171123, Abcam), Staining:Article Title: Decursin‐Loaded Nanovesicles Target Macrophages Driven by the Pathological Process of Atherosclerosis Article Snippet: Consequently, ALD@EM represents a promising nanocarrier system for increasing the therapeutic efficacy of antiatherosclerotic agents such as decursin, offering potential advancements in the management and treatment of atherosclerosis. .. The following materials were used in this study: decursin (SML0786, Sigma‒Aldrich); Mem‐PERTM Plus Membrane Protein Extraction Kit (89 842, Thermo Fisher); Oil Red O Staining Kit (C0157S, Beyotime), Nile Red (72 485, Sigma‒Aldrich), Coomassie Brilliant Blue Staining (P0017, Beyotime); dimethyl sulfoxide (276 855, Sigma‒Aldrich), DSPE‐PEG‐NHS (HY‐W441014, MedChemExpress), low density lipoprotein (L3486, Thermo Fisher); Enhanced Cell Counting Kit‐8 (C0041, Beyotime); DiD (C1039, Beyotime); Calcein/PI Live/Dead Cell Viability/Cytotoxicity Assay Kit (C2015 M, Beyotime); and antibodies against ICAM‐1 (ab171123, Abcam), CCK-8 Assay:Article Title: Decursin‐Loaded Nanovesicles Target Macrophages Driven by the Pathological Process of Atherosclerosis Article Snippet: Consequently, ALD@EM represents a promising nanocarrier system for increasing the therapeutic efficacy of antiatherosclerotic agents such as decursin, offering potential advancements in the management and treatment of atherosclerosis. .. The following materials were used in this study: decursin (SML0786, Sigma‒Aldrich); Mem‐PERTM Plus Membrane Protein Extraction Kit (89 842, Thermo Fisher); Oil Red O Staining Kit (C0157S, Beyotime), Nile Red (72 485, Sigma‒Aldrich), Coomassie Brilliant Blue Staining (P0017, Beyotime); dimethyl sulfoxide (276 855, Sigma‒Aldrich), DSPE‐PEG‐NHS (HY‐W441014, MedChemExpress), low density lipoprotein (L3486, Thermo Fisher); Enhanced Cell Counting Kit‐8 (C0041, Beyotime); DiD (C1039, Beyotime); Calcein/PI Live/Dead Cell Viability/Cytotoxicity Assay Kit (C2015 M, Beyotime); and antibodies against ICAM‐1 (ab171123, Abcam), |